For: | Teng YC, Shen ZQ, Kao CH, Tsai TF. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes. World J Gastroenterol 2016; 22(1): 300-325 [PMID: 26755878 DOI: 10.3748/wjg.v22.i1.300] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/300.htm |
Number | Citing Articles |
1 |
Ying Liang, Tianli Zhang, Mengdie Shi, Shuo Zhang, Yaxing Guo, Jiwei Gao, Xingsheng Yang. Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway. Journal of Cellular Biochemistry 2019; 120(4): 6237 doi: 10.1002/jcb.27911
|
2 |
Mohd Suhail, Sayed Sartaj Sohrab, Mohammad Amjad Kamal, Esam Ibraheem Azhar. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913231
|
3 |
Shuangfeng Li, Shuangshuang Yin, Hui Ding, Yingying Shao, Shiyue Zhou, Weiling Pu, Lifeng Han, Tao Wang, Haiyang Yu. Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention. Cell Proliferation 2023; 56(1) doi: 10.1111/cpr.13346
|
4 |
Amany Helmy Hasanin, Eman K Habib, Nesreen El Gayar, Marwa Matboli. Promotive action of 2-acetylaminofluorene on hepatic precancerous lesions initiated by diethylnitrosamine in rats: Molecular study. World Journal of Hepatology 2021; 13(3): 328-342 doi: 10.4254/wjh.v13.i3.328
|
5 |
Ting Shen, Wei Min Wu, Wen Han Du, Lin Wang, La Gu He, Li Tan, ZeYou Wang, Ruohong Chen, Min Hu, Ya Ping Ren. Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0384-3
|
6 |
Lihua Wang, Zheng Zhu, Lei Han, Liqian Zhao, Jialei Weng, Hongbao Yang, Shijia Wu, Kaiyuan Chen, Liang Wu, Tongke Chen. A curcumin derivative, WZ35, suppresses hepatocellular cancer cell growthviadownregulating YAP-mediated autophagy. Food & Function 2019; 10(6): 3748 doi: 10.1039/C8FO02448K
|
7 |
Wei Yang, Jin Zhao, Yake Wang, Haiwei Xu, Zhenwei Wu, Yangyang Hu, Kunkun Jiang, Pengpeng Shen, Cuiyun Ma, Zhenzhen Guan, Yan Zhang, Jiahui Ma, Ning Shang, Guangming Yan, Zhenji Wang, Guifu Dai. In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis. Toxicology and Applied Pharmacology 2017; 327: 1 doi: 10.1016/j.taap.2017.04.022
|
8 |
Qin Tang, Qi Wang, Qiong Zhang, Sheng-Yan Lin, Yanhong Zhu, Xiangliang Yang, An-Yuan Guo. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3860-x
|
9 |
Sharon Wei Ling Lee, Giulia Adriani, Erica Ceccarello, Andrea Pavesi, Anthony Tanoto Tan, Antonio Bertoletti, Roger Dale Kamm, Siew Cheng Wong. Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00416
|
10 |
Ruifan Ye, Ninggao Dai, Qikuan He, Pengyi Guo, Yukai Xiang, Qiong Zhang, Zhong Hong, Qiyu Zhang. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2018; 105: 962 doi: 10.1016/j.biopha.2018.06.065
|
11 |
Young-Hsiang Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee, Bing-Jie Shen, Liang-Cheng Chen, Dai-Wei Liu, Wei-Ta Tsai, Po-Hao Lin, Yi-Ting Shih, Feng-Chun Hsu, Shiang-Jiun Tsai, Michael W.Y. Chan, Hon-Yi Lin. Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma. Medicine 2016; 95(34): e4717 doi: 10.1097/MD.0000000000004717
|
12 |
Yuanyuan Wang, Junli Hao, Xiaohong Liu, Hongxin Wang, Xin Zeng, Jing Yang, Lei Li, Xi Kuang, Tao Zhang. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0232-5
|
13 |
Carmine Izzo, Monica Annunziata, Giuseppe Melara, Roberta Sciorio, Marcello Dallio, Mario Masarone, Alessandro Federico, Marcello Persico. The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials. Nutrients 2021; 13(3): 933 doi: 10.3390/nu13030933
|
14 |
Yih-Lin Chung, Mei-Ling Wu. Dual oncogenic and tumor suppressor roles of the promyelocytic leukemia gene in hepatocarcinogenesis associated with hepatitis B virus surface antigen. Oncotarget 2016; 7(19): 28393 doi: 10.18632/oncotarget.8613
|
15 |
Catherine Yujia Gu, Terence Kin Wah Lee. Preclinical mouse models of hepatocellular carcinoma: An overview and update. Experimental Cell Research 2022; 412(2): 113042 doi: 10.1016/j.yexcr.2022.113042
|
16 |
Zuzana Macek Jilkova, Keerthi Kurma, Thomas Decaens. Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment. Cancers 2019; 11(10): 1487 doi: 10.3390/cancers11101487
|
17 |
Zhao-Qing Shen, Yi-Fan Chen, Jim-Ray Chen, Yuh-Shan Jou, Pei-Chun Wu, Cheng-Heng Kao, Chih-Hao Wang, Yi-Long Huang, Chian-Feng Chen, Ting-Shuo Huang, Yu-Chiau Shyu, Shih-Feng Tsai, Lung-Sen Kao, Ting-Fen Tsai. CISD2 Haploinsufficiency Disrupts Calcium Homeostasis, Causes Nonalcoholic Fatty Liver Disease, and Promotes Hepatocellular Carcinoma. Cell Reports 2017; 21(8): 2198 doi: 10.1016/j.celrep.2017.10.099
|